NEU 0.92% $19.32 neuren pharmaceuticals limited

Ann: Neuren completes enrolment in INTREPID clinical trial

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.